CN Patent
CN1103810C — 含苯基硼酸衍生物酶稳定剂的液冻组合物
Assigned to Novozymes AS · Expires 2003-03-26 · 23y expired
What this patent protects
本发明涉及含酶和式(I)的苯基硼酸衍生物酶稳定剂的液体组合物,其中R选自氢、羟基、C 1 -C 6 烷基、取代的C 1 -C 6 烷基、C 1 -C 6 链烯基和取代的C 1 -C 6 链烯基。
USPTO Abstract
本发明涉及含酶和式(I)的苯基硼酸衍生物酶稳定剂的液体组合物,其中R选自氢、羟基、C 1 -C 6 烷基、取代的C 1 -C 6 烷基、C 1 -C 6 链烯基和取代的C 1 -C 6 链烯基。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.